Short News


short news

Medical Education
Conference at FMH

LAHORE: Fatima Memorial Hospital College of Medicine & dentistry in collaboration with Noor International University is organizing an International Conference on Medical Education from November 30 to December 2, 2018.

Surgical Week for
Colorectal Diseases at JPMC

KARACHI: JPMC is organizing 13th Annual Surgical Week for Colorectal Diseases from October 8-11, 2018. Prof. Francia Seow-Choen and Prof. Roger Motson are the Master Trainer.

Women & Men experience different
benefits from Low-Calorie Diets

A low-calorie diet causes different metabolic effects in women than in men, a new Diabetes, Obesity and Metabolism study suggests. In the study of more than 2,000 overweight individuals with pre-diabetes who followed a low-calorie diet for 8 weeks, men lost significantly more body weight than women, and they had larger reductions in a metabolic syndrome score, a diabetes indicator, fat mass, and heart rate. Women had larger reductions in HDL-cholesterol, hip circumference, lean body mass (or fat free mass), and pulse pressure than men.

Despite adjusting for the differences in weight loss, it appears that men benefitted more from the intervention than women. Whether differences between genders persist in the long-term and whether we will need to design different interventions depending on gender will be interesting to follow, said lead author Dr. Pia Christensen, of the University of Copenhagen, in Denmark. However, the 8-week low-energy diet in individuals with pre-diabetes did result in the initial 10% weight loss needed to achieve major metabolic improvement in the first phase of a diabetes prevention programme.

Can Medical Marijuana help
treat Intractable Epilepsy?

A new British Journal of Clinical Pharmacology review examines the potential of medicinal cannabis—or medical marijuana—for helping patients with intractable epilepsy, in which seizures fail to come under control with standard anticonvulsant treatment.The authors note that cannabidiol the most researched compound of cannabis—may have modest efficacy and be appropriate for children with severe epilepsy, but attention must be paid to potential side effects and drug interactions. There is no evidence to guide physicians in ranking cannabidiol among current antiepileptic drugs, and it will be important to continue studying its potential through rigorous clinical trials.

The emergence over the past 12 months of the first successful double-blind randomized controlled trials of cannabidiol is good news for some desperate families of children with severe epilepsy. These studies are a reminder though that this drug is no miracle, and we still have much to learn,â said co-author Dr. John Anthony Lawson, of Sydney Children’s Hospital, Randwick, in Australia.

© Professional Medical Publications. All rights reserved.